Genomics and epigenomics of hypertension

Current Opinion in Molecular Therapeutics

Volumn 8, Issue 3, 2006, Pages 206-214

  Fornage, Myriam ^a   Doris, Peter A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Epigenetics; Gene expression; Genetics; Hypertension; Linkage; Single nucleotide polymorphism

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALDOSTERONE SYNTHASE; CHLORIDE CHANNEL; DNA; MINERALOCORTICOID RECEPTOR; PROTEIN SERINE THREONINE KINASE; SODIUM CHANNEL; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; STEROID 11BETA MONOOXYGENASE;

BLOOD PRESSURE REGULATION; DNA MODIFICATION; EPIGENETICS; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC LINKAGE; GENETIC REGULATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MOLECULAR GENETICS; MONOGENIC DISORDER; NONHUMAN; PATHOPHYSIOLOGY; POPULATION RESEARCH; REVIEW; RISK ASSESSMENT; STROKE;

EPISTASIS, GENETIC; GENOMICS; HUMANS; HYPERTENSION;

EID: 33744940566     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P: The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension (2004) 44(4):398-404.
2. Guyton AC: Blood pressure control - special role of the kidneys and body fluids. Science (1991) 252(5014):1813-1816.
3. Kaplan NM, Lieberman E: Kaplan's Clinical hypertension. 8th Edition, Lippincott Williams & Wilkins, Baltimore, MD, USA (2002).
4. Braunwald E: Shattuck lecture - cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med (1997) 337(19):1360-1369.
5. Guttmacher AE, Collins FS: Genomic medicine - a primer. N Engl J Med (2002) 347(19):1512-1520.
6. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD et al: The sequence of the human genome. Science (2001) 291(5507):1304-1351.
7. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R et al: Initial sequencing and analysis of the human genome. Nature (2001) 409(6822):860-921.
8. The International HapMap Consortium: The International HapMap Project. Nature (2003) 426(6968):789-796.
9. Ward R: Familial aggregation and genetic epidemiology of blood pressure. In: Hypertension: Pathophysiology, Diagnosis, and Management. Laragh JH, Brenner BM (Eds), Raven Press, New York, NY, USA (1995):67-88.
10. Sing CF, Stengard JH, Kardia SL: Dynamic relationships between the genome and exposures to environments as causes of common human diseases. World Rev Nutr Diet (2004) 93:77-91.
11. Strohman RC: Linear genetics, non-linear epigenetics: Complementary approaches to understanding complex diseases. Integr Physiol Behav Sci (1995) 30(4):273-282.
12. Lifton RP, Gharavi AG, Geller DS: Molecular mechanisms of human hypertension. Cell (2001) 104(4):545-556.
13. Samani NJ: Genome scans for hypertension and blood pressure regulation. Am J Hypertens (2003) 16(2):167-171.
14. Province MA, Kardia SL, Ranade K, Rao DC, Thiel BA, Cooper RS, Risch N, Turner ST, Cox DR, Hunt SC, Weder AB et al: A meta-analysis of genome-wide linkage scans for hypertension: The National Heart, Lung and Blood Institute Family Blood Pressure Program. Am J Hypertens (2003) 16(2):144-147.
15. Kardia SL, Rozek LS, Krushkal J, Ferrell RE, Turner ST, Hutchinson R, Brown A, Sing CF, Boerwinkle E: Genome-wide linkage analyses for hypertension genes in two ethnically and geographically diverse populations. Am J Hypertens (2003) 16(2):154-157.
16. Ranade K, Hinds D, Hsiung CA, Chuang LM, Chang MS, Chen YT, Pesich R, Hebert J, Chen YD, Dzau V, Olshen R et al: A genome scan for hypertension susceptibility loci in populations of Chinese and Japanese origins. Am J Hypertens (2003) 16(2):158-162.
17. Rao DC, Province MA, Leppert MF, Oberman A, Heiss G, Ellison RC, Amett DK, Eckfeldt JH, Schwander K, Mockrin SC, Hunt SC: A genome-wide affected sibpair linkage analysis of hypertension: The HyperGEN network. Am J Hypertens (2003) 16(2):148-150.
18. Thiel BA, Chakravarti A, Cooper RS, Luke A, Lewis S, Lynn A, Tiwari H, Schork NJ, Weder AB: A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. Am J Hypertens (2003) 16(2):151-153.
19. Lalouel JM: Large-scale search for genes predisposing to essential hypertension. Am J Hypertens (2003) 16(2):163-166.
20. Morrison AC, Cooper R, Hunt S, Lewis CE, Luke A, Mosley TH, Boerwinkle, E: Genome scan for hypertension in nonobese African Americans: The National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hypertens (2004) 17(9):834-838.
21. Pausova Z, Gaudet D, Gossard F, Bernard M, Kaldunski ML, Jomphe M, Tremblay J, Hudson TJ, Bouchard G, Kotchen TA, Cowley AW, Hamet P: Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension (2005) 46(6):1280-1285.
22. Padmanabhan S, Wallace C, Munroe PB, Dobson R, Brown M, Samani N, Clayton D, Farrall M, Webster J, Lathrop M, Caulfield M et al: Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. Hypertension (2006) 47(1):1-6.
23. Laragh JH: Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int (1993) 44(5):1163-1175.
24. Blumenfeld JD, Laragh JH: Renin system analysis: A rational method for the diagnosis and treatment of the individual patient with hypertension. Am J Hypertens (1998) 11(7):894-896.
25. Hauser ER, Watanabe RM, Duren WL, Bass MP, Langefeld CD, Boehnke M: Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol (2004) 27(1):53-63.
26. Freedman BI, Bowden DW, Rich SS, Valis CJ, Sale MM, Hicks PJ, Langefeld CD: A genome scan for all-cause end-stage renal disease in African Americans. Nephrol Dial Transplant (2005) 20(4):712-718.
27. Turner ST, Fornage M, Jack CR Jr, Mosley TH, Kardia SL, Boerwinkle E, de Andrade M: Genomic susceptibility loci for brain atrophy in hypertensive sibships from the GENOA study. Hypertension (2005) 45(4):793-798.
28. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science (1996) 273(5281):1516-1517.
29. Agarwal A, Williams GH, Fisher ND: Genetics of human hypertension. Trends Endocrinol Metab (2005) 16(3):127-133.
30. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, Clayton D, Brown M, Samani N, Dominiczak A, Connell JM et al: Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study. Hum Mol Genet (2005) 14(13):1805-1814.
31. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E: WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension (2005) 46(4):758-765.
32. Kokubo Y, Kamide K, Inamoto N, Tanaka C, Banno M, Takiuchi S, Kawano Y, Tomoike H, Miyata T: Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet (2004) 49(9):507-515.
33. Marchini J, Donnelly P, Cardon LR: Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet (2005) 37(4):413-417.
34. Moore JH: The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered (2003) 56(1-3):73-82.
35. Tong AH, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost RL, Chang M, Chen Y et al: Global mapping of the yeast genetic interaction network. Science (2004) 303(5659):808-813.
36. Wagner A: Robustness against mutations in genetic networks of yeast. Nat Genet (2000) 24(4):355-361.
37. Culverhouse R, Klein T, Shannon W: Detecting epistatic interactions contributing to quantitative traits. Genet Epidemiol (2004) 27(2):141-152.
38. Zerba KE, Ferrell RE, Sing CF: Complex adaptive systems and human health: The influence of common genotypes of the apolipoprotein E (ApoE) gene polymorphism and age on the relational order within a field of lipid metabolism traits. Hum Genet (2000) 107(5):466-475.
39. Kitano H: Biological robustness. Nat Rev Genet (2004) 5(11):826-837.
40. Hartman JL, Garvik B, Hartwell L: Principles for the buffering of genetic variation. Science (2001) 291(5506):1001-1004.
41. Hartwell L: Genetics. Robust interactions. Science (2004) 303(5659):774-775.
42. Schaid DJ, McDonnell SK, Hebbring SJ, Cunningham JM, Thibodeau SN: Nonparametric tests of association of multiple genes with human disease. Am J Hum Genet (2005) 76(5):780-793.
43. Williams SM, Ritchie MD, Phillips JA 3rd, Dawson E, Prince M, Dzhura E, Willis A, Semenya A, Summar M, White BC, Addy JH et al: Multilocus analysis of hypertension: A hierarchical approach. Hum Hered (2004) 57(1):28-38.
44. Nickerson DA, Kolker N, Taylor SL, Rieder MJ: Sequence-based detection of single nucleotide polymorphisms. Methods Mol Biol (2001) 175:29-35.
45. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA: Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet (2004) 74(1):106-120.
46. Kruglyak L: Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet (1999) 22(2):139-144.
47. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES: Linkage disequilibrium in the human genome. Nature (2001) 411(6834): 199-204.
48. Altshuler D, Brooks LD, Chakravarti A, Collins FS, Daly MJ, Donnelly P: A haplotype map of the human genome. Nature (2005) 437(7063):1299-1320.
49. NIEHS: National Institute of Environmental Health Sciences Environmental Genome Project. Company Website http://egp.gs.washington.edu/finished_genes.html
50. SeattleSNPs: SeattleSNPs Variation Discovery Resource. Company Website http://pga.mbt.washington.edu
51. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, Frazer KA, Cox DR: Whole-genome patterns of common DNA variation in three human populations. Science (2005) 307(5712):1072-1079.
52. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengard J, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF: Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 63(4):595-612.
53. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF: Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet (2000) 67(4):881-900.
54. Nakajima T, Jorde LB, Ishigami T, Umemura S, Emi M, Lalouel JM, Inoue I: Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet (2002) 70(1):108-123.
55. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J, Salomaa V, Vartiainen E, Boerwinkle E, Sing CF: DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet (1998) 19(3):233-240.
56. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, Schunkert H, Doering A, Jacob HJ, Cooper RS, Rieder MJ: Localization of a small genomic region associated with elevated ACE. Am J Hum Genet (2000) 67(5):1144-1153.
57. Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC et al: Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 29(2):233-237.
58. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN et al: The structure of haplotype blocks in the human genome. Science (2002) 296(5576):2225-2229.
59. Liu N, Sawyer SL, Mukherjee N, Pakstis AJ, Kidd JR, Kidd KK, Brookes AJ, Zhao H: Haplotype block structures show significant variation among populations. Genet Epidemiol (2004) 27(4):385-400.
60. Shifman S, Kuypers J, Kokoris M, Yakir B, Darvasi A: Linkage disequilibrium patterns of the human genome across populations. Hum Mol Genet (2003) 12(7):771-776.
61. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH: Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science (2004) 305(5685):869-872.
62. Reich DE, Lander ES: On the allelic spectrum of human disease. Trends Genet (2001) 17(9):502-510.
63. Wright AF, Hastie ND: Complex genetic diseases: Controversy over the Croesus code. Genome Biol (2001) 2(8):1-8.
64. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J et al: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet (1999) 22(3):231-238.
65. Chakravarti A: Population genetics - making sense out of sequence. Nat Genet (1999) 21 (1 Suppl):56-60.
66. Sham PC, Zhao JH, Curtis D: The effect of marker characteristics on the power to detect linkage disequilibrium due to single or multiple ancestral mutations. Ann Hum Genet (2000) 64(Pt 2): 161-169.
67. Khoury MJ, Wagener DK: Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors. Am J Hum Genet (1995) 56(4):835-844.
68. Clayton D, McKeigue PM: Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet (2001) 358(9290):1356-1360.
69. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, Spielman RS: Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet (2003) 33(3):422-425.
70. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS et al: Genetics of gene expression surveyed in maize, mouse and man. Nature (2003) 422(6929):297-302.
71. Doris PA, Fomage M: The transcribed genome and the heritable basis of essential hypertension. Cardiovasc Toxicol (2005) 5(2):95-108.
72. Rockman MV, Wray GA: Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol (2002) 19(11):1991-2004.
73. Hahn MW, Rockman MV, Soranzo N, Goldstein DB, Wray GA: Population genetic and phylogenetic evidence for positive selection on regulatory mutations at the factor VII locus in humans. Genetics (2004) 167(2):867-877.
74. Rockman MV, Hahn MW, Soranzo N, Goldstein DB, Wray GA: Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr Biol (2003) 13(23):2118-2123.
75. Rockman MV, Hahn MW, Soranzo N, Loisel DA, Goldstein DB, Wray GA: Positive selection on MMP3 regulation has shaped heart disease risk. Curr Biol (2004) 14(17):1531-1539.
76. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT: Mapping determinants of human gene expression by regional and genome-wide association. Nature (2005) 437(7063):1365-1369.
77. Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, Musilova A et al: Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet (2005) 37(3):243-253.
78. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, Cheung VG: Genetic analysis of genome-wide variation in human gene expression. Nature (2004) 430(7001):743-747.
79. Jiang YH, Bressler J, Beaudet AL: Epigenetics and human disease. Annu Rev Genomics Hum Genet (2004) 5:479-510.
80. Jaenisch R, Bird A: Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet (2003) 33(Suppl):245-254.
81. Bird AP: CpG-rich islands and the function of DNA methylation. Nature (1986) 321(6067):209-213.
82. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG: Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet (2001) 10(7):687-692.
83. Issa JP: CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol (2000) 249:101-118.
84. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet (1994) 7(4):536-540.
85. Singhal RP, Mays-Hoopes LL, Eichhorn GL: DNA methylation in aging of mice. Mech Ageing Dev (1987) 41(3):199-210.
86. Wilson VL, Jones PA: DNA methylation decreases in aging but not in immortal cells. Science (1983) 220(4601):1055-1057.
87. Illi B, Nanni S, Scopece A, Farsetti A, Biglioli P, Capogrossi MC, Gaetano C: Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression. Circ Res (2003) 93(2):156-161.
88. Kotelevtsev Y, Brown RW, Fleming S, Kenyon C, Edwards CR, Secki JR, Mullins JJ: Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J Clin Invest (1999) 103(5):683-689.
89. Stewart PM, Corrie JE, Shackleton CH, Edwards CR: Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest (1988) 82(1):340-349.
90. Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM: Epigenetic regulation of 11 β-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest (2004) 114(8):1146-1157.
91. Murrell A, Rakyan VK, Beck S: From genome to epigenome. Hum Mol Genet (2005) 14(Spec No 1): R3-R10.
92. Clark AG, Boerwinkle E, Hixson J, Sing CF: Determinants of the success of whole-genome association testing. Genome Res (2005) 15(11):1463-1467.
93. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM: A chimaeric 11 β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature (1992) 355(6357):262-265.
94. Lifton RP, Dluhy RG, Powers M, Ulick S, Lalouel JM: The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension. Trans Assoc Am Physicians (1992) 105:64-71.
95. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC: Human hypertension caused by mutations in the kidney isozyme of 11 β-hydroxysteroid dehydrogenase. Nat Genet (1995) 10(4):394-399.
96. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP: Hypertension caused by a truncated epithelial sodium channel γ subunit: Genetic heterogeneity of Liddle syndrome. Nat Genet (1995) 11(1):76-82.
97. Hansson JH, Schild L, Lu Y, Wilson TA, Gautschi I, Shimkets R, Nelson-Williams C, Rossier BC, Lifton RP: A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA (1995) 92(25):11495-11499.
98. Shimkets RA, Wamock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR Jr, Ulick S, Milora RV, Findling JW et al: Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell (1994) 79(3):407-414.
99. Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ et al: Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet (1996) 12(1):24-30.
100. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP: Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet (1996) 13(2):183-188.
101. Simon DB, Karet FE, Rodriguez-Soriano J, Hamdan JH, DiPietro A, Trachtman H, Sanjad SA, Lifton RP: Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet (1996) 14(2):152-156.
102. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J et al: Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet (1997) 17(2):171-178.
103. Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP: Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet (1998) 19(3):279-281.
104. Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP: Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet (1996) 12(3):248-253.
105. Strautnieks SS, Thompson RJ, Gardiner RM, Chung E: A novel splicesite mutation in the γ subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet (1996) 13(2):248-250.
106. Strautnieks SS, Thompson RJ, Hanukoglu A, Dillon MJ, Hanukoglu I, Kuhnie U, Seckl J, Gardiner RM, Chung E: Localisation of pseudohypoaldosteronism genes to chromosome 16p12.2-13.11 and 12p13.1-pter by homozygosity mapping. Hum Mol Genet (1996) 5(2):293-299.
107. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP et al: Human hypertension caused by mutations in WNK kinases. Science (2001) 293(5532):1107-1112.